Eli Lilly's Mounjaro succeeds in second weight-loss study - STAT
- Eli Lilly's Mounjaro succeeds in second weight-loss study STAT
- Powerful new obesity drug poised to upend weight loss care Yahoo News
- Diabetes drug Mounjaro could be FDA approved for weight loss by late 2023: Eli Lilly ABC News
- Eli Lilly says obesity drug tirzepatide resulted in weight loss of up to 34 pounds CNBC
- Popular diabetes drug Mounjaro shows weight loss results in new study GMA
- View Full Coverage on Google News